Leadership: Page 14
-
Podcast
Woman of the Week: Kronos Bio's Barbara Kosacz
Deal-maker, mentor and biotech industry mover and shaker, the COO and general counsel brings her 'smiling tiger' skills to her new role at the emerging company.
By Taren Grom • June 21, 2022 -
The public health sleuth
In her decades-long career, Mary Pittman, CEO of the Public Health Institute, has seen — and helped solve — one public health mystery after another.
By Alexandra Pecci • June 21, 2022 -
Trendline
Commercialization, marketing and social media
As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical.
By PharmaVoice staff -
#DIA2022: How the industry's top regulator views the future of healthcare
In the evolution of healthcare, data is the linchpin to making drug development more efficient.
By Michael Gibney • June 21, 2022 -
A patient-funded ALS drug offers hope where few treatments exist
Eledon Pharmaceuticals’ grassroots-backed drug recently entered clinical trials.
By Kelly Bilodeau • June 15, 2022 -
Profile
Buoyed by COVID-19 shot, J&J's vaccines head sees a new golden age approaching
Janssen’s goal to have ‘a vaccine for the world’ is part of what drew Penny Heaton to the company and its work.
By Alexandra Pecci • June 14, 2022 -
Q&A // First 90 Days
First 90 Days: Editas Medicine’s Gilmore O’Neill
The first-time CEO is flexing new muscles as he steers the gene editing company through clinical trials and beyond.
By Michael Gibney • June 13, 2022 -
Making Moves
Making moves: Civica, Astellas, Inozyme and more announce key new hires
The latest hiring moves from Civica, Astella, Inozyme and the Flagship Pioneering-founded Tessera Therapeutics.
By Karissa Waddick • June 13, 2022 -
Sponsored by ClinicalMind
4 steps to making data work for you
"Analytics" can sometimes feel like a four-letter word. Here are four steps to building a successful data-driven culture. No data science degree required.
June 13, 2022 -
As cancer innovations thrive, patient access is the next piece of the puzzle
Why enhanced clinical trials and diagnostics are keys to boosting patient access to cancer care.
By Michael Gibney • June 8, 2022 -
Podcast
Woman of the Week: Janssen’s Najat Khan
Janssen’s Najat Khan, Ph.D., chief data science officer and global head of strategy and operations, shares how the company is using next-gen tech to ‘reimagine’ medicine.
By Taren Grom • June 8, 2022 -
Profile
After losing her daughter to a rare disease, Sharon King is looking to rewrite the playbook of drug development
The communications pro is lending her community-building, storytelling expertise to the Bespoke Gene Therapy Consortium.
By Alexandra Pecci • June 7, 2022 -
Q&A // First 90 Days
First 90 Days: Janssen Immunology’s David Jimenez
The long-time company man discusses the mega-drugmaker’s plans for growth and why, if you meet with him, you should plan on sipping coffee.
By Taren Grom • June 6, 2022 -
How to build a cancer pipeline: Big Pharma oncology heads on driving science forward
Executives leading the cancer departments at J&J, Merck and Takeda chime in on what it takes to construct a successful and sustainable oncology drug pipeline.
By Michael Gibney • June 6, 2022 -
Profile
Flagship's creative approach to finding the next big idea in biopharma
Avak Kahvejian, partner at Flagship Pioneering, a company that conceives, creates and launches bioplatform companies like Moderna, discusses its latest venture, ProFound Therapeutics.
By Alexandra Pecci • June 1, 2022 -
Podcast
Woman of the Week: OcuTerra Therapeutics' Kerrie Brady
The serial entrepreneur and now head of OcuTerra explains why taking risks in pharma pays off.
By Taren Grom • June 1, 2022 -
Q&A // First 90 Days
First 90 Days: Sosei Heptares’ Chris Cargill
The company’s new CEO is looking to drive growth through collaboration and transparency.
By Kim Ribbink • May 31, 2022 -
PBMs under fire for drug prices defend their worth
A new Senate bill is putting PBMs in the crosshairs of lawmakers — but they argue that they're more than just middlemen.
By Michael Gibney • May 26, 2022 -
Making Moves
Making moves: Inovio, Veru, MindMed and more announce key new hires
The latest career moves in the biopharma industry from Veru, MindMed, Horizon Therapeutics and Inovio.
By Karissa Waddick • May 25, 2022 -
Q&A // First 90 Days
First 90 Days: Syneos Health’s Michelle Keefe
The newly minted CEO is leaning on her 30 years of experience leading high-performance teams to make her mark at Syneos.
By Taren Grom • May 23, 2022 -
Tracking trends in healthcare, from tech to patient care
High-performing leaders honored by the Healthcare Businesswomen’s Association share their views on the future of the industry.
By Taren Grom • May 20, 2022 -
Q&A
Ironwood Pharmaceuticals is charting a course to become a giant in GI
Ironwood’s CEO, Tom McCourt, discusses the company’s strategy for leveling up in the GI market.
By Karissa Waddick • May 19, 2022 -
Podcast
Woman of the Week: Sparrow Pharmaceuticals' Jamie MacPherson
The vice president of regulatory affairs and quality on embracing leadership challenges in drug development.
By Taren Grom • May 18, 2022 -
Profile
Jumping into pharma with big plans at a small company
SpringWorks Therapeutics' chief medical officer on the ambition that drives him and his company to develop treatments for cancer patients.
By Alexandra Pecci • May 17, 2022 -
Opinion
Why 'soft' skills matter in the new era of leadership
Standout leaders honored by the Healthcare Businesswomen's Association discuss the rising value of the interpersonal approach.
By Taren Grom • May 12, 2022 -
Profile
With the shine of amyloid fading, tau is a rising star in Alzheimer's
The tau theory in Alzheimer's is being put to the test with phase 3 trial results due later this month from TauRx Pharmaceuticals.
By Michael Gibney • May 11, 2022